- $101.55m
- $100.31m
- $24.01m
- 40
- 12
- 74
- 37
Annual balance sheet for Genasys, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 27.6 | 18.9 | 19.1 | 10.1 | 12.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.44 | 7.68 | 6.74 | 5.95 | 3.35 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 40.1 | 35.5 | 35.6 | 25.2 | 26.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.21 | 6.62 | 6.3 | 5.44 | 4.4 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 66.2 | 90.1 | 71.9 | 49.9 | 53.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10.3 | 17.5 | 15.4 | 11.3 | 14.1 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 17 | 24.2 | 21.5 | 16.1 | 36.4 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 49.1 | 66 | 50.4 | 33.8 | 17.6 |
| Total Liabilities & Shareholders' Equity | 66.2 | 90.1 | 71.9 | 49.9 | 53.9 |
| Total Common Shares Outstanding |